Prescription drug · NDA
Gozellix (Gozetotide) NDC 84552-500
Kit · Telix Innovations SA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84552-500-25 | 84552050025 | 1 KIT in 1 CARTON (84552-500-25) * 2.5 mL in 1 VIAL, MULTI-DOSE (84552-502-25) * 6.4 mL in 1 VIAL, MULTI-DOSE (84552-503-64) * 2 mL in 1 AMPULE (84552-504-25) * 1 POWDER, FOR SOLUTION in 1 VIAL, MULTI-DOSE (84552-501-25)Marketed from Mar 20, 2025 | |
| 84552-500-64 | 84552050064 | 1 KIT in 1 CARTON (84552-500-64) * 2.5 mL in 1 VIAL, MULTI-DOSE (84552-502-25) * 6.4 mL in 1 VIAL, MULTI-DOSE (84552-503-64) * 2 mL in 1 AMPULE (84552-504-25) * 1 POWDER, FOR SOLUTION in 1 VIAL, MULTI-DOSE (84552-501-25)Marketed from Mar 20, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gozellix
- Generic name (nonproprietary)
- gozetotide
- Dosage form
- Kit
- Labeler
- Telix Innovations SANDC labeler code 84552
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 219592
- Marketing start
- Listing expires
- Identifiers
- Product ID 84552-500_334df051-2b2d-01fe-e063-6394a90a05f5SPL ID 334df051-2b2d-01fe-e063-6394a90a05f5SPL set ID abeab169-e38e-433a-b8a9-f1dab31518c8
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N484552050025followed by a unit qualifier and the quantityPackage 84552-0500-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
GOZELLIX, after radiolabeling with Ga 68, is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: With suspected metastasis who are candidates for initial definitive therapy. With suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. GOZELLIX, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: With suspected metastasis who are candidates for initial definitive therapy. With suspected recurrence based on elevated serum prosta…
Excerpt only. Read the full label for complete information.
About NDC 84552-500
- What is NDC 84552-500?
- 84552-500 is the product NDC for Gozellix (gozetotide) kit, listed with the FDA by Telix Innovations SA. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Gozellix (Gozetotide).
- Who is the labeler?
- Telix Innovations SA, NDC labeler code 84552. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Gozellix?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.